13F HOLDINGS REPORT
Octagon Capital Advisors LP
Quarter ended Q3 2025 · Filed November 14, 2025 · Accession 0001839435-25-000010
Total Value
$659.8M
Positions
27
Other Managers
0
Confidential Omitted
No
Holdings (27)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | ABIVAX SA | AAVXF | 1,325,000 | $112.5M | 17.05% |
| 2 | DIANTHUS THERAPEUTICS INC | DNTH | 2,416,667 | $95.1M | 14.41% |
| 3 | GOSSAMER BIO INC | GOSS | 17,050,000 | $44.8M | 6.80% |
| 4 | COGENT BIOSCIENCES INC | COGT | 2,874,111 | $41.3M | 6.26% |
| 5 | ARRIVENT BIOPHARMA INC | AVBP | 1,971,054 | $36.4M | 5.51% |
| 6 | OCULAR THERAPEUTIX INC | OCUL | 2,624,000 | $30.7M | 4.65% |
| 7 | TAYSHA GENE THERAPIES INC | TSHA | 9,067,500 | $29.7M | 4.49% |
| 8 | MERUS N V | N5749R100 | 308,000 | $29.0M | 4.40% |
| 9 | TREVI THERAPEUTICS INC | TRVI | 2,815,000 | $25.8M | 3.90% |
| 10 | MIND MEDICINE MINDMED INC | 60255C885 | 2,130,000 | $25.1M | 3.81% |
| 11 | APELLIS PHARMACEUTICALS INC | APLS | 903,500 | $20.4M | 3.10% |
| 12 | KYMERA THERAPEUTICS INC | KYMR | 360,000 | $20.4M | 3.09% |
| 13 | CENTESSA PHARMACEUTICALS PLC | CNTA | 830,000 | $20.1M | 3.05% |
| 14 | CIDARA THERAPEUTICS INC | 171757206 | 200,000 | $19.2M | 2.90% |
| 15 | PHARVARIS N V | PHVS | 722,595 | $18.0M | 2.73% |
| 16 | KALVISTA PHARMACEUTICALS INC | KALV | 1,273,333 | $15.5M | 2.35% |
| 17 | CORBUS PHARMACEUTICALS HLDGS | CRBP | 1,115,000 | $14.1M | 2.14% |
| 18 | BRIDGEBIO ONCOLOGY THERAPEUT | BBOT | 1,043,110 | $12.1M | 1.83% |
| 19 | DBV TECHNOLOGIES S A | DBVTF | 1,018,021 | $10.2M | 1.54% |
| 20 | NUVATION BIO INC | NUVB | 2,633,334 | $9.7M | 1.48% |
| 21 | CIDARA THERAPEUTICS INC | 171757206 | 100,000 | $9.6M | 1.45% |
| 22 | MAZE THERAPEUTICS INC | MAZE | 177,667 | $4.6M | 0.70% |
| 23 | NEUROGENE INC | NGNE | 252,000 | $4.4M | 0.66% |
| 24 | UNICYCIVE THERAPEUTICS INC | UNCY | 1,000,000 | $4.4M | 0.66% |
| 25 | PEPGEN INC | PEPG | 700,000 | $3.2M | 0.49% |
| 26 | STRUCTURE THERAPEUTICS INC | GPCR | 115,000 | $3.2M | 0.49% |
| 27 | NUVATION BIO INC | NUVB | 104,112 | $385,214 | 0.06% |